Resistance of CHO cells expressing P-glycoprotein to cyclopropylpyrroloindole (CPI) alkylating agents
- 15 April 1992
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 43 (8) , 1817-1822
- https://doi.org/10.1016/0006-2952(92)90715-u
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Induction of heat-labile sites in DNA of mammalian cells by the antitumor alkylating drug CC-1065Biochemistry, 1991
- Sequence selectivity of DNA covalent modificationChemical Research in Toxicology, 1988
- Molecular basis for sequence-specific DNA alkylation by CC-1065Biochemistry, 1988
- Stereoelectronic factors influencing the biological activity and DNA interaction of synthetic antitumor agents modeled on CC-1065Journal of Medicinal Chemistry, 1988
- Total synthesis of U- 71,184, s potent new antitumor agent modeled on cc-1065Tetrahedron Letters, 1986
- Genetic and biochemical characterization of multidrug resistancePharmacology & Therapeutics, 1985
- Reaction of the Antitumor Antibiotic CC-1065 with DNA: Structure of a DNA Adduct with DNA Sequence SpecificityScience, 1984
- Preliminary toxicity studies with the DNA-binding antibiotic, CC-1065.The Journal of Antibiotics, 1984
- Pleiotropic phenotype of colchicine‐resistant CHO cells: Cross‐resistance and collateral sensitivityJournal of Cellular Physiology, 1976
- Reduced permeability in CHO cells as a mechanism of resistance to colchicineJournal of Cellular Physiology, 1974